SCHEMBL26827104

SCHEMBL26827104

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc(-c5cccc(-c6oc7ccccc7c6-c6ccccc6)c5)cc4)cc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ PLA2G2A P14555 4/20 0.44
▸ PLA2G4A P47712 4/20 0.44
▸ PTGS2 P35354 3/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ CHRM4 P08173 1/20 0.41
▸ CHRM5 P08912 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ PLA2G10 O15496 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26827185 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26827173 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26822402 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26822405 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26827143 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26822334 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26822335 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26822342 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26827092 1.00 L3MBTL1 (0.46) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1
SCHEMBL26822378 0.99 L3MBTL1 (0.45) L3MBTL1PLA2G2APLA2G4APTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230389347-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-11-30 — — US disclosed
US-20230389347-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230389347-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, RER1 L3MBTL1 131/4885PLA2G2A 2543/4885PLA2G4A 3362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback